August 30, 2016
14 min watch
Save

VIDEO: Speaker reviews barriers and advancements in glaucoma medical management

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

At Kiawah Eye, Thomas W. Samuelson, MD, reviews reasons why fewer advancements have been made in pharmacological treatment of glaucoma compared with significant advancements in surgical and laser offerings. For one, existing prostaglandins are already "first line favorites," setting the bar high for new compounds to enter the arena. However, new medical management options are emerging, including management with combinations of "MIGS and meds."